Brokerages Set Cross Country Healthcare, Inc. (NASDAQ:CCRN) Target Price at $18.54

Cross Country Healthcare, Inc. (NASDAQ:CCRNGet Free Report) has been assigned an average rating of “Hold” from the four brokerages that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating. The average 12-month target price among analysts that have covered the stock in the last year is $18.54.

A number of analysts have commented on CCRN shares. Barrington Research reiterated a “market perform” rating on shares of Cross Country Healthcare in a research report on Tuesday, December 10th. Benchmark downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. StockNews.com began coverage on Cross Country Healthcare in a research report on Tuesday, January 7th. They set a “hold” rating for the company. Truist Financial increased their target price on Cross Country Healthcare from $15.00 to $18.61 and gave the company a “hold” rating in a report on Thursday, December 5th. Finally, William Blair cut Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th.

View Our Latest Stock Analysis on CCRN

Hedge Funds Weigh In On Cross Country Healthcare

Large investors have recently added to or reduced their stakes in the business. Jane Street Group LLC grew its holdings in Cross Country Healthcare by 337.6% in the 3rd quarter. Jane Street Group LLC now owns 181,492 shares of the business services provider’s stock valued at $2,439,000 after buying an additional 140,013 shares during the period. PDT Partners LLC purchased a new stake in Cross Country Healthcare in the third quarter valued at approximately $856,000. Royce & Associates LP increased its position in Cross Country Healthcare by 51.4% during the third quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider’s stock worth $15,222,000 after purchasing an additional 384,374 shares during the last quarter. Systematic Financial Management LP raised its stake in Cross Country Healthcare by 8.5% during the third quarter. Systematic Financial Management LP now owns 1,662,730 shares of the business services provider’s stock worth $22,347,000 after purchasing an additional 130,746 shares during the period. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Cross Country Healthcare by 288.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 54,967 shares of the business services provider’s stock valued at $739,000 after purchasing an additional 40,799 shares during the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Cross Country Healthcare Trading Down 0.2 %

CCRN stock opened at $18.16 on Friday. The company’s 50-day moving average price is $15.14 and its 200 day moving average price is $14.40. Cross Country Healthcare has a 52 week low of $9.58 and a 52 week high of $23.15. The company has a market cap of $597.77 million, a P/E ratio of -363.13, a P/E/G ratio of 3.39 and a beta of 0.46.

Cross Country Healthcare Company Profile

(Get Free Report

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.